COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Rampart Bioscience creates DNA-based biologics using its proprietary HALO platform to enhance nuclear trafficking, retention, and immune evasion, advancing programs including a hypophosphatasia candidate toward the clinic.
